CEO Share Purchases Contrast Analyst Downgrades for Healthpeak

Healthpeak Properties, Inc. (NYSE:DOC) is one of the 12 Best REIT Stocks to Buy Right Now.

Amid mixed analyst sentiments, the company sees consecutive bold purchases from its CEO.

One of the prominent healthcare REITs, Healthpeak Properties, Inc. (NYSE:DOC), specializes in a diversified portfolio that includes senior housing, life science facilities, and medical office buildings. Essentially, they provide the physical spaces for the healthcare discovery and delivery process. Headquartered in Colorado, the company operates in key markets across the United States, including San Francisco, San Diego, and Boston.

Healthpeak Properties, Inc. (NYSE:DOC) announced its Q2 earnings results on July 24, 2025. Despite the FFO per share meeting the consensus estimates at $0.46 and improved tenant satisfaction scores, Scotiabank downgraded the stock’s rating from Outperform to Sector Perform. Baird keeps an outperform rating but lowered the price target $22 to $21. Meanwhile, BMO Capital maintains a Buy rating, reflecting mixed signals from analysts.

Amid these sentiments, President & CEO Scott Brinker made a significant purchase of 2,873 shares in a transaction valued at $49,990 on July 29, 2025, and 2,930 shares valued at $49,985 on July 31, 2025, signaling a strong confidence in the company’s progress. With the Insider Monkey database noting 33 hedge funds actively backing the company, the institutional support for Healthpeak Properties, Inc. (NYSE:DOC) stands modest.

While we acknowledge the potential of DOC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Best Short-Term Stocks to Invest in and 11 Best Long Term Low Risk Stocks to Invest in

Disclosure. None.